EP0864580A2 - Procédé de préparation de D-glucoronolactone - Google Patents
Procédé de préparation de D-glucoronolactone Download PDFInfo
- Publication number
- EP0864580A2 EP0864580A2 EP98104268A EP98104268A EP0864580A2 EP 0864580 A2 EP0864580 A2 EP 0864580A2 EP 98104268 A EP98104268 A EP 98104268A EP 98104268 A EP98104268 A EP 98104268A EP 0864580 A2 EP0864580 A2 EP 0864580A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- trehalose
- glucuronolactone
- oxidized
- process according
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229950002441 glucurolactone Drugs 0.000 title claims abstract description 44
- UYUXSRADSPPKRZ-UHFFFAOYSA-N D-glucuronic acid gamma-lactone Natural products O=CC(O)C1OC(=O)C(O)C1O UYUXSRADSPPKRZ-UHFFFAOYSA-N 0.000 title claims abstract description 43
- 238000000034 method Methods 0.000 title claims description 35
- UYUXSRADSPPKRZ-SKNVOMKLSA-N D-glucurono-6,3-lactone Chemical compound O=C[C@H](O)[C@H]1OC(=O)[C@@H](O)[C@H]1O UYUXSRADSPPKRZ-SKNVOMKLSA-N 0.000 title abstract description 41
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims abstract description 73
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims abstract description 70
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims abstract description 67
- 108090000790 Enzymes Proteins 0.000 claims description 11
- 102000004190 Enzymes Human genes 0.000 claims description 11
- 230000001590 oxidative effect Effects 0.000 claims description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 10
- 229920002472 Starch Polymers 0.000 claims description 7
- 238000007254 oxidation reaction Methods 0.000 claims description 7
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 7
- 239000008107 starch Substances 0.000 claims description 7
- 235000019698 starch Nutrition 0.000 claims description 7
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 6
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 6
- 239000001301 oxygen Substances 0.000 claims description 6
- 229910052760 oxygen Inorganic materials 0.000 claims description 6
- 230000003301 hydrolyzing effect Effects 0.000 claims description 5
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 claims description 5
- 229910003446 platinum oxide Inorganic materials 0.000 claims description 5
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 4
- XHCLAFWTIXFWPH-UHFFFAOYSA-N [O-2].[O-2].[O-2].[O-2].[O-2].[V+5].[V+5] Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[V+5].[V+5] XHCLAFWTIXFWPH-UHFFFAOYSA-N 0.000 claims description 4
- 229910017604 nitric acid Inorganic materials 0.000 claims description 4
- 229910001935 vanadium oxide Inorganic materials 0.000 claims description 4
- 239000003054 catalyst Substances 0.000 claims description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- 238000006056 electrooxidation reaction Methods 0.000 claims description 2
- 238000000855 fermentation Methods 0.000 claims description 2
- 230000004151 fermentation Effects 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 150000002366 halogen compounds Chemical class 0.000 claims description 2
- 150000002367 halogens Chemical class 0.000 claims description 2
- 150000002736 metal compounds Chemical class 0.000 claims description 2
- 229910017464 nitrogen compound Inorganic materials 0.000 claims description 2
- 150000002830 nitrogen compounds Chemical class 0.000 claims description 2
- 150000002894 organic compounds Chemical class 0.000 claims description 2
- 230000003647 oxidation Effects 0.000 claims description 2
- 150000002978 peroxides Chemical class 0.000 claims description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 2
- OGLCQHRZUSEXNB-UAPNVWQMSA-N (2r,3r,3ar,6ar)-2,3,6-trihydroxy-3,3a,6,6a-tetrahydro-2h-furo[3,2-b]furan-5-one Chemical compound OC1C(=O)O[C@@H]2[C@@H](O)[C@H](O)O[C@@H]21 OGLCQHRZUSEXNB-UAPNVWQMSA-N 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 14
- 238000006243 chemical reaction Methods 0.000 description 25
- 239000002904 solvent Substances 0.000 description 13
- 239000000203 mixture Substances 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 229940088598 enzyme Drugs 0.000 description 9
- 239000011541 reaction mixture Substances 0.000 description 9
- 238000013019 agitation Methods 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 8
- 239000011521 glass Substances 0.000 description 8
- 238000010992 reflux Methods 0.000 description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 150000001720 carbohydrates Chemical class 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 description 5
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000005587 bubbling Effects 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 239000003456 ion exchange resin Substances 0.000 description 4
- 229920003303 ion-exchange polymer Polymers 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 108090000604 Hydrolases Proteins 0.000 description 3
- 102000004157 Hydrolases Human genes 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 238000005187 foaming Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- -1 maltotetrose Chemical compound 0.000 description 3
- 239000007800 oxidant agent Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 2
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 2
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- HDTRYLNUVZCQOY-BTLHAWITSA-N alpha,beta-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-BTLHAWITSA-N 0.000 description 2
- 108090000637 alpha-Amylases Proteins 0.000 description 2
- HDTRYLNUVZCQOY-NCFXGAEVSA-N beta,beta-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-NCFXGAEVSA-N 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 2
- 239000000920 calcium hydroxide Substances 0.000 description 2
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- 238000010979 pH adjustment Methods 0.000 description 2
- 239000011736 potassium bicarbonate Substances 0.000 description 2
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 2
- 235000015497 potassium bicarbonate Nutrition 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 235000011181 potassium carbonates Nutrition 0.000 description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 2
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 125000000647 trehalose group Chemical group 0.000 description 2
- 150000003625 trehaloses Chemical class 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- OHVLMTFVQDZYHP-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CN1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O OHVLMTFVQDZYHP-UHFFFAOYSA-N 0.000 description 1
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- 108010074725 Alpha,alpha-trehalose phosphorylase Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108010028688 Isoamylase Proteins 0.000 description 1
- FTNIPWXXIGNQQF-UHFFFAOYSA-N Maltopentose Chemical compound OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(OC4C(OC(O)C(O)C4O)CO)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O FTNIPWXXIGNQQF-UHFFFAOYSA-N 0.000 description 1
- 108010057899 Maltose phosphorylase Proteins 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-N Nitrous acid Chemical compound ON=O IOVCWXUNBOPUCH-UHFFFAOYSA-N 0.000 description 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- FYGDTMLNYKFZSV-DZOUCCHMSA-N alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-DZOUCCHMSA-N 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 229910021506 iron(II) hydroxide Inorganic materials 0.000 description 1
- NCNCGGDMXMBVIA-UHFFFAOYSA-L iron(ii) hydroxide Chemical compound [OH-].[OH-].[Fe+2] NCNCGGDMXMBVIA-UHFFFAOYSA-L 0.000 description 1
- 150000002611 lead compounds Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
- C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
- C07H9/04—Cyclic acetals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B61/00—Other general methods
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/04—Disaccharides
Definitions
- This invention relates to a process for producing D-glucuronolactone, more specifically, to a process for producing D-glucuronolactone by oxidizing trehalose and then hydrolyzing the oxidized trehalose.
- the present invention has been accomplished under these circumstances and aims at providing a process for producing D-glucuronolactone which gives high yield and which can be easily implemented on an industrial scale.
- This object of the invention can be attained by a process for producing D-glucuronolactone comprising the steps of oxidizing trehalose, then hydrolyzing the oxidized trehalose to form D-glucuronolactone and recovering the same.
- the sequence of reactions that take place in the process of the invention for producing D-glucuronolactone is indicated below by Scheme 1 (provided that the first reaction starts with ⁇ , ⁇ -trehalose):
- the source and origin of the treahalose to be used in the invention are not limited in any particular way.
- the applicable trehalose may be an extract from bacteria, fungi, algae or insects or it may be obatined from maltose by the action of a complex enzyme system consisting of maltose phosphorylase and trehalose phosphorylase; alaternatively, maltose may be directly converted to trehalose with a maltose-trehalose converting enzyme, or a partial hydrolyzate of starch may be saccharified enzymatically.
- the trehalose produced by either the third or fourth method may be purified by a suitable method to produce trehalose of a higher purity and this is desirably used as the starting trehalose.
- the trehalose content of the product is further enhanced by using the two enzymes in combination with a starch debranching enzyme such as isoamylase or pullulanase.
- a starch debranching enzyme such as isoamylase or pullulanase.
- the maltose-trehalose converting enzyme disclosed in Japanese Patent Public Disclosure Nos. 170977/1995, 263/1996, the specification of Japanese Patent Application No. 187901/1994 and Japanese Patent Public Disclosure No. 149980/1996 may be allowed to act on either maltose or a sugar composition containing maltose.
- trehalose is dissolved in a suitable solvent, for example, at least one solvent selected from among water and straight-chain or branched lower alcohols such as methanol, ethanol, butanol and isopropyl alcohol and, thereafter, at least one known oxidizer selected from among inorganic nitrogen compounds such as nitric acid, nitrous acid and salts thereof, metal compounds such as manganese, chromium and lead compounds, halogens, inorganic halogen compounds, oxygen species such as air, oxygen and ozone, peroxides such as peroxonic acid, and organic compounds such as nitrobenzene, is added to oxidize the trehalose.
- a suitable solvent for example, at least one solvent selected from among water and straight-chain or branched lower alcohols such as methanol, ethanol, butanol and isopropyl alcohol and, thereafter, at least one known oxidizer selected from among inorganic nitrogen compounds such as nitric acid, nitrous acid and salts thereof, metal compounds such as
- Trehalose oxidation can advantageously be performed in the presence of an oxidizing catalyst such as platinum oxide, platinum on carbon, vanadium oxide or palladium on carbon, which are used to accelerate the oxidizing reaction, Trehalose can also be oxidized by electrooxidation or microbial oxidative fermentation.
- an oxidizing catalyst such as platinum oxide, platinum on carbon, vanadium oxide or palladium on carbon, which are used to accelerate the oxidizing reaction
- Trehalose can also be oxidized by electrooxidation or microbial oxidative fermentation.
- water can advantageously be used as the solvent, oxygen, ozone or air as the oxidizer, and platinum oxide or platinum on carbon as the oxidizing catalyst.
- the oxidation reaction temperature should be high enough to allow for the progress of the reaction but insufficient to decompose trehalose, oxidized trehalose and D-glucuronolactone; typically, the oxidation reaction temperature is selected from the range of ca. 0 - 200°C, preferably ca. about 20 - 150°C, more preferably ca. 40 - 130°C, most preferably ca. 60 - 100°C.
- the time of oxidation reaction depends on the oxidizer used and the temperature and it is typically in the range of ca. 1 - 150 h, preferably ca. 5 - 80 h, more preferably ca. 10 - 30 h.
- the oxidation reaction is preferably performed with pH adjustment, which is effectively done with pH typically in the range of 5 - 10, preferably 6 - 9, more preferably 7 - 8.
- Any bases that will not Interfere with the reaction may be used for pH adjustment.
- Examples that may be used include sodium hydroxide, potassium hydroxide, calcium hydroxide, sodium carbonate, potassium carbonate, calcium carbonate, sodium hydrogendcarbonate, potassium hydrogencarbonate, magnesium hydroxide, ferrous hydroxide, ammonia, and alkylamines (e.g. trimethylamine, triehylamine, dimethylamine, diethylamine, monomethylamine, monoethylamine and so forth),
- oxidized trehalose can be produced in high yields of at least 95% relative to the trehalose used as the raw material.
- Hydrolysis of the oxidized trehalose can be easily accomplished by reacting it with one or more hydrolyzers selected from among acids such as hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid and tosic acid in one or more solvents selected from among water and straight-chain or branched lower alcohols such as methanol, ethanol, butanol and ispropyl alcohol.
- hydrolyzers selected from among acids such as hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid and tosic acid in one or more solvents selected from among water and straight-chain or branched lower alcohols such as methanol, ethanol, butanol and ispropyl alcohol.
- Other methods of hydrolysis include the use of hydrolases.
- the temperature during hydrolysis which depends on the hydrolase used is selected from the range of ca. 0 - 200°C, preferably ca. 20 - 150°C, more preferably ca. 40 - 130°C, most preferably ca. 60 - 100
- reaction product which contains D-glucuronolatone can typically be used as such after the unreacted reagents and/or the solvents are separated by filtration, extraction, solid-liquid separation, fractional precipitation, dialysis distillation, and so forth.
- Example 1-1 Preparation of oxidized trehalose
- Example 1-2 Production of D-glucuronolactone from oxidized trehalose
- Example 2-2 Production of D-glucuronolactone from oxidized trehalose
- Example 3-2 Production of D-glucuronolactone from oxidized trehalose
- Example 4-2 Production of D-glucuronolactone from oxidized trehalose
- the present invention not only improves the yield off D-glucuronolactone; it also eliminates foaming from the process of production of D-glucuronolactone and, hence the throughput of D-glucuronolactone per batch is remarkably increased to achieve a significatn improvement in reactor's efficiency. Therefore, one may well say that the process of the invention for producing D-glucuronolactone is an industrially superior approach that features a by far higher efficiency in the production of D-glucuronolactone than the currently practiced processes.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP05507597A JP4153057B2 (ja) | 1997-03-10 | 1997-03-10 | D−グルクロノラクトンの製造方法 |
| JP55075/97 | 1997-03-10 | ||
| JP5507597 | 1997-03-10 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| EP0864580A2 true EP0864580A2 (fr) | 1998-09-16 |
| EP0864580A3 EP0864580A3 (fr) | 1998-11-04 |
| EP0864580B1 EP0864580B1 (fr) | 2003-06-04 |
Family
ID=12988591
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP98104268A Expired - Lifetime EP0864580B1 (fr) | 1997-03-10 | 1998-03-10 | Procédé de préparation de D-glucuronolactone |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US5912361A (fr) |
| EP (1) | EP0864580B1 (fr) |
| JP (1) | JP4153057B2 (fr) |
| KR (1) | KR100538682B1 (fr) |
| DE (1) | DE69815179T2 (fr) |
| TW (1) | TW476759B (fr) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005002611A1 (fr) * | 2003-06-27 | 2005-01-13 | Indena S.P.A. | Preparations destinees au traitement de troubles arthritiques |
| EP2049199B1 (fr) * | 2006-08-08 | 2018-06-13 | INDENA S.p.A. | Compositions pour le traitement des maladies inflammatoires dégénératives chroniques |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6335464B1 (en) | 1997-09-08 | 2002-01-01 | Chugai Seiyaku Kabushiki Kaisha | Process for selectively oxidizing primary hydroxyl groups of organic compounds, and resin containing adsorbed catalyst for use therein |
| JP2002153294A (ja) * | 2000-11-21 | 2002-05-28 | Hayashibara Biochem Lab Inc | グルクロン酸類及び/又はd−グルクロノラクトンの製造方法とその用途 |
| WO2005059152A1 (fr) * | 2003-12-18 | 2005-06-30 | Cerestar Holding B.V. | Oxydation de carbohydrates au moyen de peroxydases et de radicaux nitroxy |
| US7923231B2 (en) * | 2004-12-17 | 2011-04-12 | Cargill, Incorporated | Production of glucuronic acid using myo-inositol oxygenase from cryptococcus neoformans |
| JP2006314223A (ja) * | 2005-05-11 | 2006-11-24 | Yokohama Kokusai Bio Kenkyusho:Kk | グルクロン酸及び/又はグルクロノラクトンの製造方法 |
| US8530186B2 (en) | 2007-05-08 | 2013-09-10 | Ensuiko Sugar Refining Co., Ltd. | Method for producing glucuronic acid by glucuronic acid fermentation |
| JP6046338B2 (ja) | 2011-10-27 | 2016-12-14 | 株式会社Ihi | ラジカル抑制剤 |
| KR20230119689A (ko) * | 2020-12-14 | 2023-08-16 | 솔루젠, 인코포레이티드 | 고순도 히드록시카르복시산 조성물 및 그 제조방법 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB670929A (en) * | 1949-12-17 | 1952-04-30 | Corn Prod Refining Co | Improvements in or relating to a method of preparing uronic acids and derivaties thereof |
| GB727471A (en) * | 1950-10-17 | 1955-04-06 | Corn Prod Refining Co | Improvements in or relating to a process of recovering glucuronolactone |
| ATE182359T1 (de) * | 1992-12-28 | 1999-08-15 | Hayashibara Biochem Lab | Nichtreduzierendes saccharidbildendes enzym, und dessen herstellung und verwendungen |
| JP3559585B2 (ja) * | 1993-06-03 | 2004-09-02 | 株式会社林原生物化学研究所 | トレハロース遊離酵素とその製造方法並びに用途 |
| JP3633648B2 (ja) * | 1993-07-20 | 2005-03-30 | 株式会社林原生物化学研究所 | マルトース・トレハロース変換酵素とその製造方法並びに用途 |
| US5871993A (en) * | 1994-02-23 | 1999-02-16 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | DNA encoding enzyme, recombinant DNA and enzyme, transformant, and their preparations and uses |
| KR100374449B1 (ko) * | 1994-03-07 | 2003-09-06 | 가부시끼가이샤 하야시바라 세이부쓰 가가꾸 겐꾸조 | 효소를인코우드하는디엔에이(dna),재조합디엔에이(dna)와효소,형질전환체및이들의제조방법과용도 |
| JP3650632B2 (ja) * | 1994-06-16 | 2005-05-25 | 株式会社林原生物化学研究所 | マルトースをトレハロースに変換する組換え型酵素 |
| US5714368A (en) * | 1994-06-24 | 1998-02-03 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Thermostable non-reducing saccharide-forming enzyme its production and uses |
| JP3810457B2 (ja) * | 1994-10-01 | 2006-08-16 | 株式会社林原生物化学研究所 | マルトースをトレハロースに変換する組換え型耐熱性酵素 |
| KR100670929B1 (ko) * | 2005-06-29 | 2007-01-17 | 서울옵토디바이스주식회사 | 플립칩 구조의 발광 소자 및 이의 제조 방법 |
| KR100727471B1 (ko) * | 2005-12-01 | 2007-06-13 | 세메스 주식회사 | 유체 공급 장치 및 방법 |
-
1997
- 1997-03-10 JP JP05507597A patent/JP4153057B2/ja not_active Expired - Fee Related
-
1998
- 1998-03-09 US US09/037,089 patent/US5912361A/en not_active Expired - Fee Related
- 1998-03-10 KR KR1019980007943A patent/KR100538682B1/ko not_active Expired - Fee Related
- 1998-03-10 DE DE69815179T patent/DE69815179T2/de not_active Expired - Fee Related
- 1998-03-10 TW TW087103477A patent/TW476759B/zh not_active IP Right Cessation
- 1998-03-10 EP EP98104268A patent/EP0864580B1/fr not_active Expired - Lifetime
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005002611A1 (fr) * | 2003-06-27 | 2005-01-13 | Indena S.P.A. | Preparations destinees au traitement de troubles arthritiques |
| JP2007513051A (ja) * | 2003-06-27 | 2007-05-24 | インデナ エッセ ピ ア | 関節炎の状態を治療するための製剤 |
| AU2004253242B2 (en) * | 2003-06-27 | 2010-02-18 | Indena S.P.A. | Formulations for the treatment of arhritis conditions |
| US8343554B2 (en) | 2003-06-27 | 2013-01-01 | Indena S.P.A. | Formulations for the treatment of arthritis conditions |
| EP2049199B1 (fr) * | 2006-08-08 | 2018-06-13 | INDENA S.p.A. | Compositions pour le traitement des maladies inflammatoires dégénératives chroniques |
| NO343552B1 (no) * | 2006-08-08 | 2019-04-01 | Indena Spa | Sammensetninger for behandling av kroniske degenerative inflammatoriske tilstander |
Also Published As
| Publication number | Publication date |
|---|---|
| DE69815179D1 (de) | 2003-07-10 |
| JPH10251263A (ja) | 1998-09-22 |
| KR100538682B1 (ko) | 2006-02-28 |
| EP0864580A3 (fr) | 1998-11-04 |
| DE69815179T2 (de) | 2004-05-19 |
| TW476759B (en) | 2002-02-21 |
| JP4153057B2 (ja) | 2008-09-17 |
| KR19980080086A (ko) | 1998-11-25 |
| EP0864580B1 (fr) | 2003-06-04 |
| US5912361A (en) | 1999-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0028136B1 (fr) | Procédé pour la production de D-glucosone et de D-fructose | |
| US4521252A (en) | Process for producing a high-purity isomaltose | |
| US5912361A (en) | Process for producing D-glucuronolactone | |
| EP0631569B1 (fr) | Production de xylitol | |
| EP0054066B1 (fr) | Procede de fabrication de glucozone | |
| KR100308524B1 (ko) | 광학적으로 순수한 (s)-3-히드록시-감마-부티로락톤의 제조방법 | |
| US4423149A (en) | Process for the production of D-glucosone | |
| FI97393B (fi) | Glyoksyylihapon valmistus glykolihapon entsymaattisella hapetuksella | |
| JP3834393B2 (ja) | D−エリトロースの製造方法 | |
| HU183630B (en) | Process for preparing glucosone | |
| JP2006314223A (ja) | グルクロン酸及び/又はグルクロノラクトンの製造方法 | |
| JP2606854B2 (ja) | イソプリメベロースの製造方法 | |
| JP4224267B2 (ja) | 配糖体の精製方法 | |
| EP0004720A1 (fr) | Production de solutions riches en mannitol à partir du glucose | |
| KR100392711B1 (ko) | 생체고분자의분해에의한알킬(d)-3-히드록시부티레이트의제조방법 | |
| JP3965223B2 (ja) | エリスリトールの精製方法 | |
| JP4241886B2 (ja) | 配糖体の精製方法 | |
| EP0314959A1 (fr) | Hydrolyse sélective | |
| JPH06113875A (ja) | L−ガラクトースの製造方法 | |
| JP3183763B2 (ja) | 光学活性1−ベンジルオキシ−2−アルカノールの製造方法 | |
| JPH05276969A (ja) | 高純度マルトオリゴ糖の製法 | |
| CN113151375A (zh) | 一种酶法制备蔗糖-6-乙酸酯的方法 | |
| JPH0731492A (ja) | 精製オリゴ糖の製造方法 | |
| HK1119743A (en) | Method for producing glucuronic acid and/or glucuronolactone | |
| JPH05105641A (ja) | グリオキシル酸水溶液中のグリオキサールの除去方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): DE FR GB |
|
| AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
| PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
| AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
| 17P | Request for examination filed |
Effective date: 19990322 |
|
| AKX | Designation fees paid |
Free format text: DE FR GB |
|
| 17Q | First examination report despatched |
Effective date: 20010627 |
|
| GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
| GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| AK | Designated contracting states |
Designated state(s): DE FR GB |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
| REF | Corresponds to: |
Ref document number: 69815179 Country of ref document: DE Date of ref document: 20030710 Kind code of ref document: P |
|
| ET | Fr: translation filed | ||
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| 26N | No opposition filed |
Effective date: 20040305 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20070320 Year of fee payment: 10 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20070326 Year of fee payment: 10 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20070213 Year of fee payment: 10 |
|
| GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20080310 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20081125 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20081001 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080331 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080310 |